Topical CsA 0.05% twice daily may be helpful in the treatment of MGD mainly by improving tear film stability.
No takes yet. Share an insight, caveat, or question.
Prabhasawat et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: